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 Summary
  Vascular malformations pose a diagnostic and therapeutic challenge due to the broad differential 
diagnosis as well as common utilization of inadequate or inaccurate classification systems among 
healthcare providers. Therapeutic approaches to these lesions vary based on the type, size, and 
extent of the vascular anomaly, necessitating accurate diagnosis and classification. Magnetic 
resonance (MR) imaging (MRI) is an effective modality for classifying vascular anomalies due 
to its ability to delineate the extent and anatomic relationship of the malformation to adjacent 
structures. In addition to anatomical mapping, the complete evaluation of vascular anomalies 
includes hemodynamic characterization. Dynamic time-resolved contrast-enhanced MR 
angiography provides information regarding hemodynamics of vascular anomalies, differentiating 
high- and low-flow vascular malformations. Radiologists must identify the MRI features of 
vascular malformations for better diagnosis and classification.
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Background
Vascular malformations (VMs) are developmental anoma-
lies, which often become symptomatic in late adolescence 
or adulthood and thus usually remain undiagnosed during 
childhood [1]. Historically, numerous classification schemes 
have existed, causing considerable confusion among cli-
nicians regarding appropriately classifying and treating 
them. Besides, nomenclature inconsistencies such as the 
use of the terms ‘hemangioma’ and ‘vascular malforma-
tion’ synonymously by many exacerbate this confusion 
[2]. The landmark work done by Mulliken and Glowacki, 
published in 1982, helped ameliorate much of the dispar-
ity, broadly classifying vascular lesions as vascular tumors 
(hemangiomas) and vascular malformations [3]. While the 
original work differentiates lesions based on histological 
components, i.e., arterial, venous, capillary, and lymphatic, 
a useful imaging strategy is to classify VMs as high-flow 
or low-flow lesions based upon the degree of shunting and 
speed of flow through the lesion [4].
This is an important distinction, as management strategies 
may differ for high- and low-flow lesions, with the former 
often requiring some means of flow control using sclero-
sant injection or embolization prior to ablation.
Contrast-enhanced computed tomography (CT) or CT angi-
ography is useful in the assessment of vascular malfor-
mations. Multi-detector CT helps to evaluate for vascular 
anatomy, enhancement, calcification, thrombus, phlebo-
liths, and involvement of adjacent structures. CT provides 
high temporal resolution and is relatively easy to interpret. 
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Hepatic hemangiomas are typically diagnosed on contrast-
enhanced CT as hypoattenuating lesions on non-contrast 
sequence, with peripheral globular enhancement on early 
arterial phase. There is a progressive centripetal enhance-
ment on venous phase, causing uniform filling. The uni-
form enhancement persists on delayed images. However, 
CT has an overall limited utility, as it provides less infor-
mation on the flow dynamics, and is associated with expo-
sure to ionizing radiation. Hence, ultrasound (US) and MR 
are the primary noninvasive imaging modalities for the 
evaluation of vascular malformations [5,6].
Although ultrasound is used to differentiate high-flow 
from low-flow lesions, MR imaging has proven advanta-
geous due to its reproducibility, ability to reliably deline-
ate the extent of these lesions, and its ability in differen-
tiating high-flow VMs from low-flow VMs using dynamic 
post-contrast sequences. Due to these benefits, coupled 
with the lack of ionizing radiation and multi-planar capa-
bilities, MRI has become the first-line imaging modality in 
the assessment of vascular malformations in many institu-
tions [7–10]. In this review, we present typical MR imag-
ing appearances of VMs, including examples from different 
body regions, to illustrate their ubiquitous occurrence and 
aid the radiologist in correctly classifying and diagnosing 
these lesions.
Classification and Management
Multiple classification systems have been proposed for the 
characterization and categorization of vascular anomalies. 
The first major classification system was presented in 1982 
by Mulliken and Glowacki, who classified vascular anoma-
lies into two major categories based on their biological and 
pathological characteristics including cellular growth rate 
and turnover, histologic features, physical examination 
findings, and natural history of the lesion [3]. The classifi-
cation separated the vascular anomalies into hemangiomas 
(vascular tumors) and vascular malformations, and was 
adopted by the International Society for the Study of the 
Vascular Anomalies (ISSVA) at the 1996 ISSVA workshop 
(Table 1) [11]. The inclusion of radiologic findings within 
the classification system was proposed by Jackson et al. 
in 1993, and then vascular malformations were further 
divided into the high-flow and low-flow lesions based on 
their flow characteristics [12,13]. Low-flow malformations 
include venous, lymphatic, capillary, and any combination 
of the mentioned vessels. High-flow malformations include 
arteriovenous (AV) malformations and AV fistulas (AVF).
This flow characteristic-based categorization has impli-
cations for management: a suitably located slow-flow 
lesion may be amenable to sclerotherapy in one or multi-
ple sessions, depending on the size of the malformation [4]. 
Treatment of high-flow vascular malformations usually 
requires flow control in the form of tourniquet applica-
tion or embolization prior to sclerotherapy. It is important 
to note that among vascular malformations, high-flow 
and diffuse vascular malformations are difficult to treat 
and result in more frequent complications as well as early 
recurrence. Table 2 demonstrates treatment strategy based 
on histopathology and flow dynamics, as recommend-
ed by Jackson et al. [4]. Today, the most commonly used 
classification systems are the ISSVA classification and the 
Hamburg classification system, which utilizes embryologic 
characterization of vascular abnormalities in addition to 
anatomic and pathological features [14].
Epidemiology and Clinical Presentation
As part of the initial work-up and characterization of vas-
cular malformations, the natural history, clinical presenta-
tion, and physical examination findings serve as a founda-
tion for further diagnostic procedures including diagnostic 
imaging.
High-flow lesions
Symptoms of high-flow lesions correspond to the degree of 
AV shunting and the involved area of the body. The prev-
alence of AVMs in the general population has not been 
characterized, however, estimates range from 5 to 613 per 
Vascular tumours (vasoproliferative) Vascular malformations
• Infantile hemangioma
• Congenital hemangiomas
 • RICH
 • NICH
• Kaposiform
 • Hemangioendothelioma
 • Tufted angiomas
• Spindle cell
 • Hemangioendothelioma
• Epithelioid
 • Hemangioendothelioma
• Other (rare)
 • Hemangioendothelioma (composite, retiform, other)
• Angiosarcoma
• Dermatologic acquired vascular tumours
• Low-flow vascular malformations
 • Capillary malformation
 • Venous malformation
 • Lymphatic malformation
• High-flow vascular malformations
 • Arterial malformation
 • Arteriovenous malformation
 • Arteriovenous fistula
•  Combined vascular malformation (combination of above lesion 
types)
Table 1. Vascular anomalies classification adopted by ISSVA. Rome 1996 [ref].
RICH – rapidly involuting congenital hemangioma; NICH – noninvoluting congenital hemangioma.
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100,000 people [15]. When fully developed, AVMs deep-
en in color and present with progressive erythema, local 
warmth, a palpable thrill, and a bruit. Patients with facial 
AVMs of the skin and/or facial bones may present with 
facial asymmetry, gingival hypertrophy, unstable teeth, 
periodontal bleeding, or skin/mucosal ulcers with second-
ary infection. Bony AVMs create osteolysis. Lower limb 
skin changes resembling brown-violaceous plaques may 
appear and are known histologically as pseudo-Kaposi sar-
comas. Distal extremity AVMs may lead to ischemia of the 
tips of fingers or toes, which is associated with an arterial 
steal and venous hypertension.
Sequelae of expanding AVMs with AV shunting may include 
ischemic changes, indolent ulceration, intractable pain, 
acute life-threatening hemorrhage, or recurrent intermit-
tent bleeding. Increased cardiac output with subsequent 
congestive heart failure occurs in less than 2% of cases 
[16]. Pain, overgrowth, and bleeding are the most common 
symptoms, while high-output cardiac failure is a relatively 
uncommon clinical presentation, seen mostly in patients 
with large AVMs. Following a localized trauma, AVMs 
may show rapid growth over a relatively short period. 
Schobinger developed a classiﬁcation (Table 3) based on 
clinical signs and symptoms for determining the severity of 
AVMs and timing of intervention [17].
Low-flow lesions
Venous malformations are present in 1–4% of the popula-
tion [18] and are non-tumorous developmental aberrations. 
Although present at birth, they are usually not detected 
until adolescence, when acute changes in lesion size or 
symptoms precipitated by growth, hormonal influence, 
infection or thrombosis may bring them to clinical atten-
tion. These lesions tend to occur more commonly in the 
head and neck (40%) and extremities (40%), and less com-
monly involve the trunk (20%) [19]. Superficially located 
venous malformations may cause bluish discoloration and 
appear as compressible non-pulsatile masses, whereas 
lesions containing arterial components tend to appear as 
pulsatile masses with palpable thrill [20]. Deeper lesions 
may be extensive, and in the extremities, can be inter-
spersed between muscular planes with atrophy of the sur-
rounding muscles due to shunting. A high recurrence rate 
is noted due to the fact that these lesions contain immature 
cellular elements, which have a propensity to regrow after 
attempted ablation [21].
Lymphatic malformations are subdivided into macrocystic 
(also known as cystic hygroma), microcystic (also known 
as cavernous lymphangioma), and mixed lesions based on 
the size of the cystic component [22,23]. Microcystic lesions 
contain endothelium-lined small cavities and cysts measur-
ing less than 2 cm3 with a background of solid matrix of 
fibrous tissue and smooth muscles. Microcystic lesions are 
the most common type and usually involve the neck, shoul-
ders, proximal limbs, and perineum. They present later in 
the childhood. Macrocytic lesions contain large, >2 cm3, 
cystic spaces filled with proteinaceous ﬂuid and some lym-
phocytes. These lesions often contain thick intralesional 
septae. Macrocystic lesions commonly involve the head 
and neck (70%) and are usually diagnosed within the ﬁrst 
2 years of life (Figure 1) [23,24]. They can also involve the 
trunk and limbs. However, the involvement of the medi-
astinum or abdomen is rare. Macrocytic lesions are typi-
cally subcutaneous with normal overlying skin and appear 
Type Histopathology Treatment
Slow flow vascular malformations Capillary malformation (port-wine stain, 
telangiectasia, angiokeratoma)
Sclerosant injection (most commonly 
alchohol and Onyx) (1)
Venous malformation
Commonly sporadic, Bean syndrome, 
glomuvenous malformation,
Mafucci syndrome
Sclerosant injection with embolization in a 
multi-disciplinary setting (2)
Lymphatic malformation Sclerosant injection
High flow vascular malformation Arterial malformation
Arteriovenous fistula (AVF)
Arteriovenous malformation (AVM)
Embolisation/direct puncture sclerotherapy 
Complex-combined vascular malformations Capillary-venous, Capillary-lymphatic, 
Lymphatic-venous, Capillary-lymphatic-
venous, AVM-lymphatic, Capillary 
malformation-AVM
Variable and depends upon relative 
proportion of low-flow and high-flow 
components.
Table 2. Overview of classification and management of vascular malformations.
Stage Clinical symptoms
I (Quiescence) Skin warmth, discoloration
II (Expansion) Enlargement, pulsation, bruit
III (Destruction) Pain, ulceration, bleeding
IV (Decompensation) Cardiac failure due to volume overload
Table 3. Schobinger classification of AVMs.
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translucent on clinical examination, while microcystic 
lesions involve the skin and mucosal surfaces. Both mac-
rocystic and microcystic lesions often present with acute 
exacerbation of their painful symptoms and rapid expan-
sion of the lesions secondary to superimposed infection or 
intralesional hemorrhage. Since venous and lymphatic mal-
formations are embryologically related, there is a consider-
able overlap in imaging characteristics [17].
MR imaging techniques
The standard sequences for characterization and diagnosis 
of suspected vascular malformations include spin echo (SE) 
or fast SE T1-weighted imaging (T1WI) for regional anato-
my, and SE T2-weighted imaging (T2WI) with and without 
fat saturation to delineate the extent of the abnormality 
(Figure 1A). Gradient recalled echo (GRE) T2* WI is invalu-
able in differentiating areas of high-flow or hemosiderin 
deposition from bleeding.
The dynamic contrast-enhanced techniques like time-
resolved MRI sequence of the lesion using three-dimen-
sional (3D) fast gradient recalled echo (GRE) technique, 
which involves image acquisition at intervals as short as 
2 seconds, has high specificity for differentiating venous 
from non-venous malformations [25,26]. This yields a 
volumetric dataset with high spatial and temporal reso-
lution, which can also facilitate digital subtraction (using 
pre-contrast mask image), volume rendering, multi-planar 
reformats (MPR), and maximum intensity projection (MIP). 
Time-resolved angiography techniques allow assessment of 
flow direction, feeder arteries and drainage veins, and dif-
ferentiation of high-flow from low-flow lesions [20,26].
Key Imaging Features
An important role of imaging is to classify vascular malfor-
mations into low-flow or high-flow lesions based on their 
hemodynamics. The distinction of low-flow from high-flow 
lesions has therapeutic and prognostic implications and is 
Figure 1.  Coronal T2 with fat suppression (A) and coronal T1 post contrast (B) demonstrate left submandibular, fluid signal intensity lesion with thin 
peripheral enhancement after contrast administration compatible with a lymphatic malformation (arrows).
A B
Modality Arteriovenous malformation
Venous 
malformation
Arteriovenous 
fistula
Pure lymphatic 
malformation 
MR features Dark T1 and T2, flow 
voids, enhances early 
with contrast, localized 
or infiltrative, enlarged 
feeding arteries and 
draining veins
Intermediate T1, bright T2, 
absent flow voids, phleboliths/
areas of thrombosis, localized or 
infiltrative, enhances gradually 
with contrast, normal feeding 
arteries and draining veins
Dark T1 and T2, flow void, 
enlarged feeding artery 
and draining vein. Early 
venous filling on dynamic 
contrast studies. 
Dark T1, bright T2, 
localized or infiltrative, 
minimal to no 
enhancement, no feeding 
arteries and draining veins
Table 4. MR features of vascular malformation.
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more relevant to management than the prediction of indi-
vidual vascular components [26,27]. Table 4 gives an over-
view of pertinent conventional and dynamic imaging find-
ings of low-flow and high-flow lesions.
Low-Flow Vascular Malformations
Pure capillary malformations are present at birth in 0.3% 
of children [28] and are mostly diagnosed clinically. When 
imaged, the only feature may be of mild skin thickening. 
The MRI appearance of slow-flow lesions depends on their 
components. Pure venous malformations appear as lobu-
lated and multi-septated masses with internal serpentine 
architecture. They exhibit intermediate to low signal 
intensity on T1- and high signal on T2-WI. The presence 
of internal hemorrhage or proteinaceous content may lend 
higher signal on T1WI or fluid-fluid levels. When pre-
sent, phleboliths are diagnostic of venous elements [29]. 
Following IV contrast administration, there is gradual 
and complete enhancement, though this tends to be ear-
lier in the case of mixed capillary venous malformations 
compared to pure VMs. Pure lymphatic malformations, on 
the other hand, do not show internal enhancement follow-
ing contrast administration, being composed entirely of 
cystic spaces non-communicating with the venous system, 
although peripheral and septal enhancement may be occa-
sionally seen (Figure 1B).
High-Flow Vascular Malformations
AVMs comprise approximately 10% of peripheral vascular 
malformations [28,30]. Their hallmark feature is the nidus, 
which is the confluence of serpentine vascular structures, 
e.g., feeder arteries and draining veins without an inter-
vening capillary bed. Identifying the nidus has manage-
ment implications, as it is frequently the target of sclero-
sant injection [7,29]. Conversely, AVFs are composed of a 
single channel between a vein and an artery. Following 
contrast administration, both types of lesions show rapid 
filling in 5–10 seconds, typically with contrast reaching the 
venous side of the lesion during the arterial phase, how-
ever, AVMs will demonstrate a confluence of many feeder 
arteries and draining veins, while AVFs will demonstrate a 
single large channel bridging the artery and vein.
The distinction between low-flow and high-flow vascular 
malformations relies on the late filling of the former and 
early filling of the latter in the arterial phase on dynamic 
contrast-enhanced MRI (DCE-MRI) (Figure 2). Other distin-
guishing features include the presence of dilated tortuous 
vessels and flow voids on spin echo images, which indicate 
high-flow components of a vascular malformation.
Pitfalls in MRI Interpretation
Calcification and phleboliths may also appear as flow-voids 
and can lead to erroneous labelling of low-flow lesions 
and high-flow lesions [31]. Since calcifications and phlebo-
liths are better visualized on CT, a non-contrast CT may 
be obtained for better identification [5]. Similarly, septa-
tions have a low signal on T2WI. These potential errors are 
reduced utilizing high signal on GRE and contrast enhance-
ment to differentiate true high-flow lesions from other 
causes of low signal on standard MRI [29].
A
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Slow-flow venous malformations might be indistinguisha-
ble from lymphoid malformations due to cystic appearance 
and sedimentation of blood products. Post-contrast imaging 
with or without fat-suppressed T1 sequence is imperative, 
as lymphoid malformations enhance peripherally, while 
venous malformations enhance homogeneously throughout 
the lesion [17].
Central Nervous System Vascular Malformations
Central nervous system (CNS) vascular malformations 
have been extensively studied owing to their profound 
sequelae and related complications [32–36]. The most com-
mon presenting symptoms for lesions in the brain are sei-
zures, headache, and focal neurological deficits. Similar to 
vascular malformations located in other organ systems, 
identifying the nature of vascular supply and differentiat-
ing a slow-flow malformation from a high-flow malforma-
tion are important determinations to be made on imaging. 
Generally, superficially located brain vascular malforma-
tions are supplied by pial arteries and drain into superficial 
cortical veins (Figure 3), whereas deeper vascular malfor-
mations are supplied by perforators e.g., the lenticulostri-
ate arteries and choroidal arteries and drain into the deep 
venous system [1].
In addition to the general characterization outlined above, 
intracranial vascular malformations have specific features 
related to sensitive functional regions, i.e., the eloquent 
cortex and involvement of adjacent brain parenchyma in 
B Figure 2.  (A) Coronal T2 fat saturation images 
demonstrate a diffuse soft tissue 
lesion in the forearm (arrow) and hand 
(arrowhead). (B) Time resolved contrast 
images of the same lesion demonstrate 
early filling of the lesion consistent with 
arteriovenous malformation.
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Figure 3.  (A) Axial T2 image (1) demonstrates a dural AVF with a large venous varix (arrowhead), which enhances on a T1 contrast-enhanced 
axial image (2). There is early enhancement of dilated veins (arrow). (B) Conventional angiogram demonstrating large dural AVF with 
distended draining veins and early filling of the sagittal sinus (arrow).
A B
Figure 4.  Sagittal MRI (T2WI) (A) and MRA (MIP images) (B) demonstrate a spinal cord AVM with an entanglement of blood vessels on the surface 
of the cord and cauda equine. AVM is demonstrated with signal void (arrow) on T2WI (A) and hyperintense signal (arrow) on MRA (B). The 
nidus (arrowhead in b) is present at the cranial end of the lesion.
A B
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vascular supply, which would naturally be affected, if the 
vascular supply to the lesion were reduced as part of treat-
ment. The Spetzler-Martin grading system is frequently 
used to score the lesions and predict post-treatment out-
come of the patient [37,38].
Spinal vascular malformations present with paresthe-
sias, motor symptoms, or autonomic dysfunction such as 
Figure 5.  Coronal STIR (A) and coronal T1 (B) post-contrast image demonstrate a large AVM of the left hand, with auto-amputation of the distal 
phalanges of the ring and little finger (arrows).
A B
Figure 6.  Coronal MRA demonstrates a gluteal 
AVM with a large tangle of vessels (arrow 
heads) supplied by branches of the 
internal iliac and the common femoral 
artery (arrows) and drainage via the 
common femoral vein (long arrow). This 
is a high-flow lesion.
incontinence or retention, depending on the spinal cord 
level involved as well as the degree of cord compression or 
ischemia due to the steal phenomenon [39]. Lesions may be 
intra-medullary or extra-medullary and similar to vascular 
malformations elsewhere, they can be high-flow, e.g. dural 
AVM (Figure 4) or low-flow lesions, with the former cate-
gory constituting about 70% of all lesions [40,41]. Diagnosis 
is based on finding a long segment enhancing serpiginous 
Review Article
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Figure 9.  Axial contrast-enhanced MRI (A) and coronal MIP (B) images demonstrate a large left lung AVM (arrows).
A B
Figure 7.  Sagittal MRA demonstrate an AVM along the plantar 
surface of the foot (arrows).
Figure 8.  Axial MRA (MIP) demonstrates an enhancing entangle of 
vessels (arrow) consistent with right renal hilum AVM.
structure within the spinal canal composed of abnormal 
vessels. Low-flow lesions demonstrating a paucity of flow-
void on MR imaging can be confused for spinal neoplasm; 
conversely, cerebrospinal fluid flow artifact can be mistak-
en for an AVM of the cord by the unwary.
Peripheral Vascular and Visceral Malformations
The majority of the peripheral vascular malformations are 
low-flow venous malformations [7]. Within the trunk and 
limbs, lesions frequently spread across several muscles 
and tissue compartments owing to their congenital nature. 
Syndromic associations have been described, including 
Proteus, Mafucci, Klippel-Trenauny-Weber [42–44] and 
blue rubber bleb syndromes [45]. On MRI, peripheral vas-
cular malformations appear as serpiginous structures with 
or without a nidus. Orientation along the long axis of the 
limb, multifocal involvement, and occasionally, the pres-
ence of atrophy of the surrounding structures may also be 
seen (Figure 5) [25,27,46]. Imaging evaluation, as a general 
principle, should take into account the presence or absence 
of a nidus, extent of lesion, and size of the affected area. As 
outlined earlier, the distinction of the lesion into high-flow 
and low-flow hemodynamic categories is critical; this, in 
turn, depends on finding dilated vascular structures and 
early venous filling on dynamic T1WI – features indicative 
of high-flow lesions. Examples of peripheral and visceral 
malformations are seen in Figures 6–9.
Management of peripheral vascular malformations is gen-
erally conservative, unless the patient develops complica-
tions such as cosmetic disfiguration, functional impair-
ment, pain, or high output cardiac failure [7]. Quite often, 
high-flow lesions are subjected to some manner of flow-
control by tourniquet or embolization prior to sclerosant 
injection into the nidus for definitive closure. Management 
decisions are based on a multidisciplinary team-approach, 
as these lesions are difficult to treat and recur frequent-
ly. As a result, multi-staged, multi-disciplinary treatment 
approaches involving a cosmetic surgeon, a vascular sur-
geon, and an interventional radiologist may be necessary 
for the larger high-flow lesions [7,47]. In contrast, smaller 
low-flow lesions can usually be treated in a single session 
of sclerosant injection. It is imperative that radiologists 
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are aware of the specific challenges faced in the manage-
ment of these lesions and structure their report to facilitate 
decision-making.
Post Therapy Changes
Percutaneous sclerotherapy is the treatment of choice for 
low-flow vascular lesions, while trans-arterial emboliza-
tion followed by surgical resection is the treatment of 
choice for high-flow lesions. MR is the imaging modality of 
choice for post-therapy evaluation of lesions [48].
Venous malformations: Immediate post therapy, T2WI 
shows hyperintense signal which persists up to 3 months. 
On MR angiography, there is an absence of enhancement in 
the central portion of the treated lesion. However, there is 
peripheral, reactive arterial enhancement up to 3 months 
post therapy. After 3 months, there is a loss of peripheral 
enhancement and a central scar may be seen which is dark 
on T1 and STIR images. Post-contrast images are impera-
tive in assessing for any residual lesions and planning sub-
sequent therapy if needed [48].
Arterial malformations and AVMs: After trans-arterial 
embolization, there is thrombosis of the lesion resulting 
in absent shunting and reduced or absent early opacifica-
tion of draining vein. Early post-therapy imaging is recom-
mended for early identification of residual malformations 
for planning the second stage of treatment [48].
Conclusions
Vascular malformations are developmental abnormalities, 
which usually do not present before puberty. MRI with 
dynamic contrast-enhanced sequences is the mainstay of 
diagnosis and characterization of these lesions. The identi-
fication of a nidus and the classification into high-flow or 
low-flow categories are important determinants of treat-
ment modality and should be sought out during the evalu-
ation of these lesions. It is important to note that despite 
optimal therapeutic intervention, many these lesions recur 
and require multiple treatment sessions and complex man-
agement decisions.
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